| 1 |
陈灏珠，钟南山，陆再英，等. 内科学[M]. 8版. 北京：人民卫生出版社，2013：41-45.
|
| 2 |
Martin-Garrido I, Carmona EM, Specks U, et al. Pneu-mocystis pneumonia in patients treated with rituximab[J]. Chest, 2013, 144 (1): 258-265.
|
| 3 |
Li MC, Lee NY, Lee CC, et al. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals[J]. J Microbiol Immunol Infect, 2014, 47 (1): 42-47.
|
| 4 |
Catherinot E, Lanternier F, Bougnoux ME, et al. Pne-umocystis jirovecii pneumonia[J]. Infect Dis Clin North Am, 2010, 24 (1): 107-138.
|
| 5 |
Datta S, Budhauliya R, Das B, et al. Next-generation sequencing in clinical virology: discovery of new viruses[J]. World J Virol, 2015, 4 (3): 265-276.
|
| 6 |
Wilson MR, Sample HA, Zorn KC, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis[J]. N Engl J Med, 2019, 380 (24): 2327-2340.
|
| 7 |
Boers SA, Jansen R, Hays JP. Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory[J]. Eur J Clin Microbiol Infect Dis, 2019, 38 (6): 1059-1070.
|
| 8 |
Forbes JD, Knox NC, Peterson CL, et al. Highlighting clinical metagenomics for enhanced diagnostic decision-making: a step towardswider implementation[J]. Comput Struct Biotechnol J, 2018 (16): 108-120.
|
| 9 |
Avino LJ, Naylor SM, Roecker AM. Pneumocystis jir-ovecii pneumonia in the non-HIV-infected population[J]. Ann Pharmacother, 2016, 50 (8): 673-679.
|
| 10 |
Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non HIV Pneumocystis carinii pneumonia[J]. Chest, 1998, 113 (5): 1215-1224.
|
| 11 |
Inoue N, Fushimi K. Adjunctive corticosteroids dec-reased the risk of mortality of non-HIV pneumocystis pneumonia[J]. Int J Infect Dis, 2019 (79): 109-115.
|
| 12 |
Fujikura Y, Manabe T, Kawana A, et al. Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in non-HIV-infected patients: a systematic review and meta-analysis of observational studies[J]. Arch Bronconeumol, 2017, 53 (2): 55-61.
|
| 13 |
Lemiale V, Debrumetz A, Delannoy A, et al. Adjun-ctive steroid in HIV-negative patients with severe Pneumocystis pneumonia[J]. Respir Res, 2013, 14 (1): 87.
|
| 14 |
Maschmeyer G, Helweg-Larsen J, Pagano L, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients[J]. J Antimicrob Chemother, 2016, 71 (9): 2405-2413.
|
| 15 |
Zhang G, Chen M, Zhang S, et al. Efficacy of caspofungin combined with trimethoprim / sulfamethoxazole as first line therapy to treat non HIV patients with severe pneumocystis pneumonia[J]. Exp Ther Med, 2018, 15 (2): 1594-1601.
|
| 16 |
Wyder MA, Johnston LQ, Kaneshiro ES. Evidence for DNA synthesis in Pneumocystis carinii trophozoites treated with the β-1,3-glucan synthesis inhibitor pneumocandin L-693,989[J]. J Eukaryot Microbiol, 2010, 57 (5): 447-448.
|
| 17 |
Utili R, Durante-Mangoni E, Basilico C, et al. Efficacy of caspofungin addition to trimethoprim-sulfamethoxazole treatment for severe pneumocystis pneumonia in solid organ transplant recipients[J]. Transplantation, 2007, 84 (6): 685-688.
|
| 18 |
Lee WS, Hsueh PR, Hsieh TC, et al. Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia[J]. J Microbiol Immunol Infect, 2017, 50 (4): 547-548.
|
| 19 |
Jiang XQ, Fang L, Mei XD, et al. Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma after rituximab-containing regimen: two cases of report and literature review[J]. J Thorac Dis, 2013, 5 (4): E162-E166.
|
| 20 |
中华医学会呼吸病学分会呼吸生理与重症监护学组，《中华结核和呼吸杂志》编辑委员会. 无创正压通气临床应用专家共识[J]. 中华结核和呼吸杂志，2009,32(2):86-98.
|
| 21 |
Akashiba T, Ishikawa Y, Ishihara H, et al. The Japanese Respiratory Society Noninvasive Positive Pressure Ventilation (NPPV) Guidelines (second revised edition)[J]. Respir Investig, 2017, 55 (1): 83-92.
|
| 22 |
黄絮，翁利，易丽，等. 非HIV免疫抑制患者肺孢子菌肺炎合并急性呼吸衰竭的临床特征[J]. 中华医学杂志，2016,96(38):3057-3061.
|
| 23 |
Monnet X, Vidal-Petiot E, Osman D, et al. Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection[J]. Crit Care, 2008, 12 (1): R28.
|
| 24 |
Chen M, Tian X, Qin F, et al. Pneumocystis pneu-monia in patients with autoimmune diseases: a retrospective study focused on clinical characteristics and prognostic factors related to death[J]. PLoS One, 2015, 10 (9): e0139144.
|
| 25 |
黄絮，翁利，易丽，等. 结缔组织病患者肺孢子菌肺炎合并急性呼吸衰竭的临床特点及预后分析[J]. 中华结核与呼吸杂志，2018,41(3):196-200.
|